- Home
- BBIO vs EAD Comparison
BBIO vs EAD Comparison
Compare BBIO & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- EAD
- Stock Information
- Founded
- BBIO 2015
- EAD 2003
- Country
- BBIO United States
- EAD United States
- Employees
- BBIO N/A
- EAD N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- EAD Finance/Investors Services
- Sector
- BBIO Health Care
- EAD Finance
- Exchange
- BBIO Nasdaq
- EAD Nasdaq
- Market Cap
- BBIO 6.7B
- EAD N/A
- IPO Year
- BBIO 2019
- EAD N/A
- Fundamental
- Price
- BBIO $34.48
- EAD $6.75
- Analyst Decision
- BBIO Strong Buy
- EAD
- Analyst Count
- BBIO 12
- EAD 0
- Target Price
- BBIO $57.09
- EAD N/A
- AVG Volume (30 Days)
- BBIO 3.2M
- EAD 178.9K
- Earning Date
- BBIO 04-29-2025
- EAD 01-01-0001
- Dividend Yield
- BBIO N/A
- EAD 8.91%
- EPS Growth
- BBIO N/A
- EAD N/A
- EPS
- BBIO N/A
- EAD N/A
- Revenue
- BBIO $127,415,000.00
- EAD N/A
- Revenue This Year
- BBIO $13.67
- EAD N/A
- Revenue Next Year
- BBIO $118.02
- EAD N/A
- P/E Ratio
- BBIO N/A
- EAD N/A
- Revenue Growth
- BBIO N/A
- EAD N/A
- 52 Week Low
- BBIO $21.62
- EAD $5.69
- 52 Week High
- BBIO $39.47
- EAD $6.81
- Technical
- Relative Strength Index (RSI)
- BBIO 49.67
- EAD 58.30
- Support Level
- BBIO $33.92
- EAD $6.71
- Resistance Level
- BBIO $39.16
- EAD $6.82
- Average True Range (ATR)
- BBIO 1.43
- EAD 0.06
- MACD
- BBIO -0.16
- EAD 0.03
- Stochastic Oscillator
- BBIO 31.05
- EAD 92.11
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.